Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Marimastat or No Further Therapy in Treating Women With Metastatic Breast Cancer That Is Responding or Stable Following Chemotherapy [Phase 3]
Phase 3 trial evaluating Marimastat maintenance or no further therapy in metastatic breast cancer responders/stable after chemotherapy.
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Limited Adjuvant Endocrine Therapy for Low Risk Breast Cancer [Phase 2]
Phase 2 clinical trial update evaluating limited adjuvant endocrine therapy for low-risk breast cancer.
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: TCb vs EC-T in High Risk ER+/HER2- Breast Cancer [Phase 3]
Phase 3 clinical trial update comparing TCb versus EC-T in high-risk ER+/HER2- breast cancer; currently recruiting.
-
CLINICAL_TRIALS trial_result · 2023-06-13Clinical Trial Update: DP303c in Patients With HER2-positive Advanced Breast Cancer [Phase 3]
A Phase 3 clinical trial update for DP303c in HER2-positive advanced breast cancer is not yet recruiting, indicating ongoing evaluation befo…
-
CLINICAL_TRIALS trial_result · 2023-06-13Clinical Trial Update: Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery [Phase 1]
Phase I trial evaluating Endoxifen Gel versus placebo in women undergoing breast surgery, including DCIS, LCIS, and various stages of breast…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-06-12Clinical Trial Update: Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer [Phase 3]
Phase 3 trial evaluating docetaxel, carboplatin, trastuzumab, and pertuzumab with or without estrogen deprivation in hormone receptor-positi…
-
CLINICAL_TRIALS trial_result · 2023-06-09Clinical Trial Update: Clinical Outcomes for Offering Genetic Testing in a Tiered Approach [NA]
A completed clinical trial evaluating the outcomes of offering genetic testing in a tiered approach, with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-06-09Clinical Trial Update: Narrative Visualization for Breast Cancer Survivors' Physical Activity [NA]
Completed clinical trial exploring narrative visualization to support breast cancer survivors' physical activity; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-06-08Clinical Trial Update: Dexmedetomedine and Ketamine in Erector Spinae Block for Postoperative Analgesia Following Mastectomy. [Phase 2, Phase 3]
A phase 2/3 clinical trial evaluating dexmedetomidine and ketamine in erector spinae block for postoperative analgesia after mastectomy has …
-
CLINICAL_TRIALS trial_result · 2023-06-08Clinical Trial Update: Pink Warrior 2: Teleconference-based Gaming Support [NA]
A completed clinical trial evaluating teleconference-based gaming support for individuals with breast cancer, with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-06-07Clinical Trial Update: Drug Resistance Inhibition in Treating Women With Recurrent or Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial update on drug resistance inhibition for women with recurrent or metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2023-06-06Clinical Trial Update: Paravertebral Block (PVC) Versus Pectoral Nerve Block (PEC) [Phase 3]
Phase 3 trial comparing paravertebral block to pectoral nerve block in breast cancer; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2023-06-05Clinical Trial Update: A Randomized, Controlled, Open-label Clinical Trial of Adjuvant Intensive Therapy for HR+/ HER2-SNF4 Early Breast Cancer [Phase 3]
A Phase 3 randomized trial evaluating adjuvant intensive therapy in HR+/HER2-negative breast cancer; status is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2023-06-05Clinical Trial Update: Stellate Ganglion Block (SGB) For Women for Breast Cancer [Phase 2]
Phase 2 clinical trial update on Stellate Ganglion Block for hot flashes in women undergoing breast cancer treatment; study completed with r…
-
CLINICAL_TRIALS trial_result · 2023-06-05Clinical Trial Update: Pilot Trial to Assess 68Ga Bombesin PET/CT (NeoB) Imaging for Staging of Breast Cancer [Phase 2]
Phase 2 pilot trial assessing 68Ga Bombesin PET/CT (NeoB) imaging for staging in breast cancer.
-
CLINICAL_TRIALS trial_result · 2023-06-02Clinical Trial Update: Preoperative Treatment of HR+/HER2+Breast Cancer With Pirotinib, Trastuzumab and AI Research [Phase 2]
Phase 2 clinical trial update exploring preoperative treatment of HR+/HER2+ breast cancer with pirotinib, trastuzumab, and an AI-based thera…
-
CLINICAL_TRIALS trial_result · 2023-06-01Clinical Trial Update: Study of Infigratinib in Combination With Tamoxifen in Hormone Receptor Positive, HER2 Negative, FGFR Altered Advanced Breast Cancer [Phase 1]
A Phase 1 trial evaluating Infigratinib in combination with Tamoxifen for hormone receptor-positive, HER2-negative FGFR-altered advanced bre…
-
FDA approval · 2023-05-31FDA Approved: LYNPARZA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for LYNPARZA (olaparib) from AstraZeneca Pharmaceuticals LP, resulting in changes to the product…
-
CLINICAL_TRIALS trial_result · 2023-05-31Clinical Trial Update: Vinorelbine Versus Gemcitabine Plus Vinorelbine in Metastatic Breast Cancer Patients [Phase 3]
Phase 3 trial comparing vinorelbine to gemcitabine plus vinorelbine in metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-05-31Clinical Trial Update: Exercise Program in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy [NA]
A completed clinical trial evaluating an exercise program in breast cancer patients receiving neoadjuvant chemotherapy; results posted.
-
CLINICAL_TRIALS trial_result · 2023-05-30Clinical Trial Update: Pyrotinib After Trastuzumab-based Adjuvant Therapy in Patients With HER2-positive Breast Cancer [Phase 2]
A Phase 2 trial evaluating pyrotinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer is ongoing, with …
-
CLINICAL_TRIALS trial_result · 2023-05-26Clinical Trial Update: Prospective Study of Particle Radiotherapy for Breast Cancer With Different Arm Position [Phase 2]
Phase 2 prospective trial assessing particle radiotherapy for breast cancer with different arm positions.
-
CLINICAL_TRIALS trial_result · 2023-05-23Clinical Trial Update: A Multicenter, Randomized, Open, Phase III Trial of ddEC-THPvs Evaluating the Efficacy and Safety of TCHP Neoadjuvant Therapy for HER2-positive Breast Cancer [Phase 3]
A multicenter, randomized Phase III trial evaluating ddEC-THP versus TCHP neoadjuvant therapy for HER2-positive breast cancer is in Phase 3 …
-
CLINICAL_TRIALS trial_result · 2023-05-18Clinical Trial Update: DEPO-Trigger Trial: GnRH Agonist DEPOt TRIGGER for Final Oocyte Maturation [Phase 1, Phase 2]
Clinical trial update for the DEPO-Trigger trial evaluating DEPOt TRIGGER GnRH agonist for final oocyte maturation in a breast cancer settin…
-
CLINICAL_TRIALS trial_result · 2023-05-17Clinical Trial Update: The Study of Vidicizumab Combined With Tirelizumab in the Treatment of Breast Cancer With Low HER2 Expression [Phase 4]
A Phase 4 study evaluating vidicizumab in combination with tirelizumab for breast cancer with low HER2 expression; current status is unknown…